Biorestorative Therapies, INC. (BRTX) — 10-Q Filings
All 10-Q filings from Biorestorative Therapies, INC.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
BioRestorative Therapies' Net Loss Widens Amid Soaring R&D Costs
— Nov 12, 2025 Risk: high
BioRestorative Therapies, Inc. (BRTX) reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $11.0 million, up from -
BRTX Narrows Q2 Loss Amidst Zero Revenue, High Burn Rate
— Aug 12, 2025 Risk: high
BioRestorative Therapies, Inc. (BRTX) reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year periods. The company' -
BioRestorative Therapies Files Q1 2025 10-Q
— May 14, 2025 Risk: low
BioRestorative Therapies, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Stem Cell Assurance, Inc., is involved in hea -
BioRestorative Therapies Files Q3 2024 10-Q
— Nov 12, 2024 Risk: medium
BioRestorative Therapies, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported its financial results and provided updates on its b -
BioRestorative Therapies Files Q2 2024 10-Q
— Aug 13, 2024 Risk: medium
BioRestorative Therapies, Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as Stem Cell Assurance, Inc., is involved in heal
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX